CYCLERION THERAPEUTICS, INC. Operating Lease, Weighted Average Discount Rate, Percent
CYCLERION THERAPEUTICS, INC. (CYCN) had Operating Lease, Weighted Average Discount Rate, Percent of 6.10% as of 2021-03-31, per its 10-Q filed 2021-04-30.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2022-02-24
- 2021-03-31: Operating Lease, Weighted Average Discount Rate, Percent 6.10%.
- 2020-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.10%.
- 2020-09-30: Operating Lease, Weighted Average Discount Rate, Percent 6.10%.
- 2020-06-30: Operating Lease, Weighted Average Discount Rate, Percent 9.70%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2021-03-31 | 6.10% 10-Q · filed 2021-04-30 |
| 2020-12-31 | 6.10% 10-K · filed 2022-02-24 |
| 2020-09-30 | 6.10% 10-Q · filed 2021-11-09 |
| 2020-06-30 | 9.70% 10-Q · filed 2021-07-29 |
| 2020-03-31 | 9.70% 10-Q · filed 2021-04-30 |
| 2019-12-31 | 10.90% 10-K · filed 2021-02-25 |
| 2019-09-30 | 10.90% 10-Q · filed 2019-11-12 |
| 2019-06-30 | 10.90% 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |